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Binding of insulin to its heterotetrameric receptor results in autophosphorylation of both beta subunits on at least six tyrosine residues [l] . This autophosphorylation results in the activation of the intrinsic tyrosine kinase towards exogenous substrates even after the dissociation of insulin [2] . The recent isolation of phosphotyrosine specific phosphatases suggests one mechanism by which insulin receptor signalling may be attenuated. Activation of the insulin receptor tyrosine kinase activity was reversed by both particulate and soluble protein tyrosine phosphatases (PTP's) from rat liver. This deactivation was shown to correlate best with the disappearance of triphosphorylation in the kinase domain (tyrosines 1158, 1162 and 1163) [3] . Further studies using permeabilised rat adipocytes have shown rapid dephosphorylation of the activated insulin receptor, suggesting that the PTP is transmembrane or membrane associated [4] . stimulation of the cells gave rise to two phosphoproteins (approximately 95kD & 160kD) which were not present in the non-treated cells. The insulin dependence of these phosphoproteins, and their ability to be precipitated by an anti-insulin receptor antibody strongly suggests that the smaller phosphoprotein is the beta subunit of the insulin receptor and the larger may be the proreceptor or IRS-1. However, only overexpression of the cytosolic form of PTPlB (clone Pb2.2) had any inhibitory effect on the phosphorylation state of this phosphoprotein (Fig. 2 lanes 3  & 4) . The cytosolic forms of LAR (clone Lc1.4) and LRP (clone C5) and the full length form of LRP (clone 84) did not appear to decrease the phosphotyrosine content of the receptor significantly phosphoprotein (Fig. 2 lanes 5-9) . Since increased expression of the catalytic domain of PTPl B (clone Pb2.2) antagonises the insulin stimulated tyrosine phosphorylation of the insulin receptor, PTPl B may be a physiologically important in insulin signalling. The inability of the LAR cytosolic construct (clone Lc1.4) to decrease insulin receptor phosphorylation may be due to its lack of membrane association [9].
However, LRP whether full length or cytosolic, had no effect on insulin receptor phosphorylation suggesting that this PTP may not be involved in insulin signalling. (done 64). Lane 9 CH0.T cells stably overexpressing cytosolic LRP (clone C5).
